Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

NCT00050076 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: MCC-135
DRUG: MCC-135
DRUG: MCC-135
DRUG: Placebo

Sponsor

Takeda